Phase 3 Study of High-Dose Biotin, MD1003, for PPMS & SPMS

A board to discuss future MS therapies in early stage (Phase I or II) trials.
Post Reply
User avatar
seeva
Family Elder
Posts: 503
Joined: Sun Jan 20, 2008 3:00 pm
Location: SYDNEY
Contact:

Phase 3 Study of High-Dose Biotin, MD1003, for PPMS & SPMS

Post by seeva » Fri May 19, 2017 6:27 am

HI Friends please read
https://multiplesclerosisnewstoday.com/ ... -patients/

A Phase 3 clinical trial has been launched by MedDay Pharmaceuticals to investigate whether treatment with high-dose biotin (MD1003) may ease disability and improve mobility in non-relapsing primary or secondary progressive MS patients. The study is recruiting participants across the U.S., Canada and Europe.

regards
seeva

Post Reply
  • Similar Topics
    Replies
    Views
    Last post